Tribunal grants refund to medical transcription company for CENVAT credit, with interest

The Tribunal set aside the impugned order rejecting refund claims, allowing the appeals of a private limited company engaged in medical transcription services for hospitals outside India. The company correctly debited the CENVAT credit account before filing the claim under Notification No.27/2012-CE(NT). The Tribunal held the company fulfilled refund conditions and was entitled to interest on delayed refund per the Supreme Court decision in Ranbaxy Laboratories Ltd. The appeals were allowed, and the company was granted relief, including interest on delayed refund.

---

---

Issues involved:
- Rejection of refund claims by the Commissioner(Appeals)
- Interpretation of Notification No.27/2012-CE(NT)
- Debiting of CENVAT credit account before filing refund claim
- Claim for interest on delayed refund

Analysis:
1. The appellant filed two appeals against the common impugned order rejecting their refund claims. The appellant, a private limited company registered as 100% EOU, provides medical transcription services for hospitals outside India under Business Auxiliary Service category. They availed cenvat credit on input services for export of services during the disputed period. The Assistant Commissioner rejected the refund claims, upheld by the Commissioner(Appeals).
2. The appellant argued that the impugned order failed to appreciate Cenvat Credit Rules and Notification No.27/2012. They contended they fulfilled conditions for refund under the Notification, debiting the claimed amount from CENVAT credit as required. They cited relevant judgments and claimed interest on delayed refund.
3. The AR supported the impugned order's findings, stating the appellant did not meet conditions 2(g) and 2(h) of the Notification. They cited judgments to support their stance.
4. The Tribunal examined whether the rejection of refund claims was legally sustainable. It noted no dispute on service export and foreign exchange receipt. The main ground for rejection was the 'nil' cenvat credit balance at the quarter end, less than the refund amount. The Tribunal found the appellant correctly debited the cenvat credit account before filing the claim. The respondent's misinterpretation of Notification conditions led to the rejection.
5. The Tribunal set aside the impugned order, allowing the appeals. It held the appellant entitled to interest on delayed refund per the Supreme Court decision in Ranbaxy Laboratories Ltd., payable after three months from the application receipt under Section 11B(1) of the Central Excise Act, 1944.
6. Consequently, both appeals were allowed, and the operative portion of the Order was pronounced on 13/10/2020.

---